Chloroquine (brand names include: Aralen / Avloclor / Cadiquin / Chlorquin / Delagil / Emquin / Lagaquin / Malaquin / Malarex / Malarivon / Nivaquine / Resochin) is a drug of the aminoquinoline class.
Chloroquine is best known as a drug effective for the prevention as well as treatment of malaria. It is also used for the treatment of extraintestinal amebiasis.
chloroquine malaria, chloroquine with proguanil, chloroquine with proguanil, chloroquine endosome, 14c-chloroquine, chloroquine kenya,
chloroquine vs mefloquine, chloroquine volume of distribution, chloroquine 100mg, chloroquine mode of action, chloroquine phosphate, chloroquine resistant malaria,
chloroquine uses, zithromax\/chloroquine for malaria, chloroquine lamp 1, chloroquine cost, chloroquine uveitis, chloroquine fda,
chloroquine xenograft, chloroquine chromatin, chloroquine 250 mg dosage, chloroquine pregnancy, chloroquine volume of distribution, chloroquine resistant malaria.
Disease-modifying antirheumatic drugs Chloroquine is effective on all five species of parasites, including some strains of P. falciparum. But in many areas P. falciparum is resistant to chloroquine, and other medicines must be used. Checkups Chloroquine-induced itching is very common among black Africans (70%), but much less common in other races. It increases with age, and is so severe as to stop compliance with drug therapy. It is increased during malaria fever; its severity is correlated to the malaria parasite load in blood. Some evidence indicates it has a genetic basis and is related to chloroquine action with opiate receptors centrally or peripherally.[12] The mechanisms behind the effects of chloroquine on cancer are currently being investigated. The best-known effects (investigated in clinical and preclinical studies) include radiosensitizing effects through lysosome permeabilization, and chemosensitizing effects through inhibition of drug efflux pumps (ATP-binding cassette transporters) or other mechanisms (reviewed in the second-to-last reference below). Chloroquine is in clinical trials as an investigational antiretroviral in humans with HIV-1/AIDS and as a potential antiviral agent against chikungunya fever.[5] Trouble breathing.